VANCOUVER, Washington, Sept. 09, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]
– This group of four dispensaries is expected to have EBITDA margins of 35% in 2019 and will be among the most profitable retail locations in the Company’s portfolio, upon transaction closing- Company is now […]
– Roots Rx is one of the top dispensary brands within Colorado, with high quality cannabis, ease of ordering features, knowledgeable budtenders, and a unique loyalty program- This transaction will add an additional six dispensaries […]
VANCOUVER, Washington, Sep 06, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]
NEW YORK, Sept. 6, 2019 — Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, […]
Upon closing of pending acquisitions, the Company will operate a total of 14 dispensaries within Colorado- The acquisitions are part of MMT’s strategy aimed at creating an integrated operation, to include proven and profitable cultivation, […]
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis to chronic wound disorders, today issued a letter to shareholders. Dear Shareholder, I […]
VANCOUVER, Washington, Sept. 04, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the […]
– The Company’s addition of a group of five dispensaries will increase the retail footprint and regional coverage of the Company in Colorado- As part of the agreement, one of the original industry pioneers, Brian […]
Phunware’s Multiscreen-as-a-Service (MaaS) Platform Provides Mixed Use Development with Unified Mobile Solution Serving Multiple Stakeholders Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands […]
Nancy Bush Huber brings over 25 years of executive management roles, primarily as CFO of several publicly traded and private companies- Most recent position was as CFO of consumer packaged goods company for 13 years- […]
VANCOUVER, Washington, Aug. 29, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]
Delivers New Feature Sets for Political and Advocacy Solutions within Phunware’s Multiscreen-as-a-Service (MaaS) Platform Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, […]
Greenville, SC, Aug. 22, 2019 — Zylo Therapeutics, dedicated to bringing innovative topical technologies to multiple facets of medicine, has entered into a definitive partnership agreement with Hoth Therapeutics (NASDAQ: HOTH) to develop a new treatment for […]
NEW YORK and TORONTO, Aug. 27, 2019 ) — NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB:NEXCF) (CSE: NTAR) (FSE:N29) is pleased to announce that it has entered into an agreement with LA Police Gear.com. LA […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
